Kenneth To is a strategic business leader with business development and commercial expertise in genomics, oncology, IVD, CDx and NGS at small and large biotech companies. He is passionate about opportunities to blend dual science and business background, in order to translate innovative technology into breakthrough diagnosis and therapies. Kenneth has experience leading large complex projects and analyzing market trends to capitalize on business opportunities. Additionally, he is an experienced problem solver with the business acumen and leadership skills to develop effective strategic relationships that enhance value. He has provided strategic guidance to teams and managers in ways that promote the company’s culture and oversee the progress of operations. 10+ years of leadership and management experiences. 15+ years of life science research experience; published original works in peer-reviewed journals.